The store will not work correctly when cookies are disabled.
2,6-Difluoro-3-{[3-(trifluoromethyl)benzyl]oxy}benzamide
ID: ALA5080731
PubChem CID: 156022394
Max Phase: Preclinical
Molecular Formula: C15H10F5NO2
Molecular Weight: 331.24
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCc2cccc(C(F)(F)F)c2)c1F
Standard InChI: InChI=1S/C15H10F5NO2/c16-10-4-5-11(13(17)12(10)14(21)22)23-7-8-2-1-3-9(6-8)15(18,19)20/h1-6H,7H2,(H2,21,22)
Standard InChI Key: LRFNHIJSGVXHPW-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
14.8745 -9.6247 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.2873 -10.3346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6957 -9.6222 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.6357 -9.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6345 -10.3534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3426 -10.7624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0522 -10.3529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0494 -9.5303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3408 -9.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3383 -8.3078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0448 -7.8971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6294 -7.9013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7606 -10.7604 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4676 -10.3507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1760 -10.7582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1726 -11.5738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8802 -11.9812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5882 -11.5715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5843 -10.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8762 -10.3463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7556 -9.1190 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.9279 -9.1254 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.9997 -10.7428 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 10 1 0
10 11 1 0
10 12 2 0
7 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
8 21 1 0
4 22 1 0
19 2 1 0
2 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.24 | Molecular Weight (Monoisotopic): 331.0632 | AlogP: 3.66 | #Rotatable Bonds: 4 |
Polar Surface Area: 52.32 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: ┄ | CX LogP: 3.55 | CX LogD: 3.55 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.87 | Np Likeness Score: -1.42 |
References
1. Huecas S, Araújo-Bazán L, Ruiz FM, Ruiz-Ávila LB, Martínez RF, Escobar-Peña A, Artola M, Vázquez-Villa H, Martín-Fontecha M, Fernández-Tornero C, López-Rodríguez ML, Andreu JM.. (2021) Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery., 64 (9.0): [PMID:33908781] [10.1021/acs.jmedchem.0c02207] |